Contemporary nationwide patterns of self-reported prostate-specific antigen screening
Menée aux Etats-Unis à partir des données 2012 d'une enquête nationale de santé portant sur 114 544 hommes âgés de 50 ans ou plus, cette étude évalue, en fonction des Etats et de catégories d'âge, la prévalence de l'usage du test PSA et identifie les facteurs prédictifs associés
Routine screening for prostate cancer using prostate-specific antigen (PSA) is a widely contested practice, and recommendations have recently changed dramatically. In October 2011, the US Preventative Services Task Force recommended against screening in any age group, yet current nationwide patterns of PSA screening are largely unknown. We sought to elucidate contemporary PSA screening prevalence with a focus on heterogeneity among states and across age groups. We examine data from the 2012 Behavioral Risk Factor Surveillance System (BRFSS).
JAMA Internal Medicine , résumé, 2013